Stay updated on Nivolumab Ibrutinib in CLL Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Ibrutinib in CLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Ibrutinib in CLL Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Page now includes a government funding status notice and new version v3.2.0; a disease term (B-cell chronic lymphocytic leukemia) was removed.
    Difference
    3%
    Check dated 2025-10-06T04:45:07.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Updated version from v3.0.2 to v3.1.0, indicating a new release. No other content changes were detected.
    Difference
    0.1%
    Check dated 2025-09-29T02:54:00.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    Update: Revision updated to v3.0.2 from v3.0.1. Also, the Back to Top element was removed.
    Difference
    0.2%
    Check dated 2025-09-14T18:50:42.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.2%
    Check dated 2025-09-07T13:24:08.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as detailed information on B-cell chronic lymphocytic leukemia and related medical conditions. Notably, the version has been updated from v2.16.12 to v3.0.0.
    Difference
    4%
    Check dated 2025-08-31T11:15:59.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.5%
    Check dated 2025-08-17T04:37:37.000Z thumbnail image

Stay in the know with updates to Nivolumab Ibrutinib in CLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Ibrutinib in CLL Clinical Trial page.